Literature DB >> 35296930

Could full thickness skin grafts in an onlay position be the new gold standard for incisional hernia repair? Author's reply.

V Holmdahl1, B Stark2, L Clay3,4, U Gunnarsson5, K Strigård5.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35296930      PMCID: PMC9012709          DOI: 10.1007/s10029-022-02589-8

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   2.920


× No keyword cloud information.
We thank Prof Berrevoet for his interest in our trial and his comments on the potential use of full-thickness skin grafting in hernia repair [1, 2]. We agree that sample size of the trial potentially decreases the statistical power of outcomes other than the main endpoint, thus increasing the risk of type 2 error. The main outcome of our trial was surgical complication at the 3-month follow-up. The lack of differences in other outcomes must therefore be interpreted with caution, and we addressed this issue in both the one-year and long-term follow-up publications. However, considering that the present trial included only the subgroup of incisional hernias deemed “giant”, the study population can be considered large, even for a tertiary referral center. This is the main reason for the relatively long inclusion time. Regarding the heterogenicity of the techniques used, the state of the art at the start of the trial must be considered. Inclusion began December 2009, and investigations on the behavior of full-thickness skin in the various positions of the abdominal wall were performed several years later [3]. This limited the full-thickness skin graft positioning in our trial to the onlay position as used in the proof-of-concept study, when in fact the sublay position may have been a better alternative [4]. Prof. Berrevoet mentions transversus abdominis release, which is a technique that is gaining in popularity, but this was introduced 2012 and could not have been used in the present trial [5]. However, new approaches and increasing knowledge in the treatment of incisional hernia also opens for new applications of full-thickness skin grafting. A final aspect is the increasing hesitancy amongst certain patient groups regarding implantation of synthetic materials. This highlights the need for development of alternative strategies such as full-thickness skin grafting. We also agree with Dr. Berrevoet, that trial results should not be spread out over an unnecessarily large number of publications, which may negatively affect readability and make it difficult to gain an overview of the outcome of the trial. We believe, however, that results of a trial should be published as soon as data are available so that as many patients benefit as soon as possible. This may result in several different publications from the same trial. Generally, the main problem with hernia surgery research is more the lack of long-term follow-up publications than the fact that long-term data result in more than one publication. Sincerely yours,
  4 in total

1.  Transversus abdominis muscle release: a novel approach to posterior component separation during complex abdominal wall reconstruction.

Authors:  Yuri W Novitsky; Heidi L Elliott; Sean B Orenstein; Michael J Rosen
Journal:  Am J Surg       Date:  2012-05-16       Impact factor: 2.565

2.  Could full thickness skin grafts in an onlay position be the new gold standard for incisional hernia repair?

Authors:  F Berrevoet
Journal:  Hernia       Date:  2022-01-31       Impact factor: 2.920

3.  Evaluating full-thickness skin grafts in intraperitoneal onlay mesh position versus onlay position in mice.

Authors:  Annika Winsnes; Ulf Gunnarsson; Peter Falk; Birgit Stark; Jan Ø Moskaug; Karin Strigård
Journal:  J Surg Res       Date:  2018-05-31       Impact factor: 2.192

4.  Long-term follow-up of full-thickness skin grafting in giant incisional hernia repair: a randomised controlled trial.

Authors:  V Holmdahl; B Stark; L Clay; U Gunnarsson; K Strigård
Journal:  Hernia       Date:  2021-12-14       Impact factor: 2.920

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.